Omada Health (OMDA) Income Statement (2024 - 2026)
Income Statement report data from Mar 31, 2024 to Mar 31, 2026 for Omada Health (OMDA).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||
Total Revenue | 78M (+2.90%) | 76M (+11.49%) | 68M (+10.85%) | 61M (+11.66%) | 55M (-33.84%) | 83M (+82.49%) | 46M (+10.46%) | 41M | - |
Cost Of Revenue | 29M (+32.37%) | 22M (-3.40%) | 23M (+8.97%) | 21M (-8.63%) | 23M (-31.35%) | 34M (+98.17%) | 17M (+3.48%) | 16M | - |
Costof Goods And Services Sold | 29M (+32.37%) | 22M (-3.40%) | 23M (+8.97%) | 21M (-8.63%) | 23M (-31.35%) | 34M (+98.17%) | 17M (+3.48%) | 16M | - |
Gross Profit | 49M (-9.26%) | 54M (+19.06%) | 45M (+11.81%) | 40M (+26.36%) | 32M (-35.53%) | 49M (+73.25%) | 29M (+15.02%) | 25M | - |
Operating Expenses | |||||||||
Research And Development | 13M (+9.96%) | 12M (+12.14%) | 10M (+2.79%) | 10M (+13.73%) | 8.81M (-51.30%) | 18M (+104.41%) | 8.85M (-1.56%) | 8.99M | - |
Selling General And Administrative | 14M (-1.62%) | 14M (-0.84%) | 14M (+16.49%) | 12M (+8.75%) | 11M (-46.60%) | 21M (+98.87%) | 11M (-0.28%) | 11M | - |
Operating Expenses | 53M (+6.13%) | 50M (+5.88%) | 48M (+6.56%) | 45M (+10.79%) | 40M (-45.96%) | 75M (+101.05%) | 37M (+6.37%) | 35M | - |
Depreciation And Amortization | 1.51M (-63.70%) | 4.16M | - | - | 1.33M (-72.29%) | 4.80M | - | - | - |
Operating Income | |||||||||
Operating Income | -4.78M | 3.28M | -2.51M (-42.17%) | -4.34M (-48.33%) | -8.40M (-66.52%) | -25.09M (+194.48%) | -8.52M (-15.14%) | -10.04M | - |
Ebit | -4.78M | 3.28M | -2.51M (-42.17%) | -4.34M (-48.33%) | -8.40M (+37.25%) | -6.12M (-28.17%) | -8.52M (-15.14%) | -10.04M (-47.07%) | -18.97M |
EBITDA | -3.27M | 7.62M | -2.82M (-33.18%) | -4.22M (-40.23%) | -7.06M (+215.18%) | -2.24M (-72.28%) | -8.08M (-15.48%) | -9.56M (-49.60%) | -18.97M |
Other Income / Expenses | |||||||||
Interest Income | 1.83M (-3.17%) | 1.89M (-5.97%) | 2.01M (+133.72%) | 860K (+59.26%) | 540K (-22.86%) | 700K (+3400.00%) | 20K (-77.78%) | 90K | - |
Interest Expense | 20K (+100.00%) | 10K (-97.14%) | 350K (-67.89%) | 1.09M (+1.87%) | 1.07M (-52.02%) | 2.23M (+93.91%) | 1.15M (+1.77%) | 1.13M | - |
Net Interest Income | 1.83M (-3.17%) | 1.89M (-5.97%) | 2.01M (+133.72%) | 860K (+59.26%) | 540K (-22.86%) | 700K (+3400.00%) | 20K (-77.78%) | 90K | - |
Other Non Operating Income | 1.81M | -810.00K (+22.73%) | -660.00K (-31.96%) | -970.00K (-7.62%) | -1.05M (-69.83%) | -3.48M (+397.14%) | -700.00K (+7.69%) | -650.00K | - |
Net Income | |||||||||
Income Before Tax | -2.97M | 5.16M | -3.18M (-40.11%) | -5.31M (-43.81%) | -9.45M (-65.28%) | -27.22M (+194.91%) | -9.23M (-13.66%) | -10.69M | - |
Net Income From Continuing Operations | -2.97M | 5.16M | -3.18M (-40.11%) | -5.31M (-43.81%) | -9.45M (+14.55%) | -8.25M (-10.62%) | -9.23M (-13.66%) | -10.69M (-43.65%) | -18.97M |
Net Income | -2.97M | 5.16M | -3.18M (-40.11%) | -5.31M (-43.81%) | -9.45M (+14.55%) | -8.25M (-10.62%) | -9.23M (-13.66%) | -10.69M (-43.65%) | -18.97M |
Comprehensive Income Net Of Tax | -2.97M (-76.76%) | -12.78M (+301.89%) | -3.18M (-40.11%) | -5.31M (-43.81%) | -9.45M (-79.95%) | -47.14M (+410.73%) | -9.23M (-13.66%) | -10.69M (-43.65%) | -18.97M |